Lassa fever


Reference articles

1. Hartnett JN, Boisen ML, Oottamasathien D, et al. Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever. Future Virol. 2015;10:559-584.Full text

2. World Health Organization. Lassa fever: fact sheet. July 2017 [internet publication].Full text

3. Monson MH, Cole AK, Frame JD, et al. Pediatric Lassa fever: a review of 33 Liberian cases. Am J Trop Med Hyg. 1987;36:408-415. Abstract

4. McCormick JB, King IJ, Webb PA, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987;155:445-455. Abstract

5. Price ME, Fisher-Hoch SP, Craven RB, et al. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ. 1988;297:584-587.Full text  Abstract

6. Cummins D, McCormick JB, Bennett D, et al. Acute sensorineural deafness in Lassa fever. JAMA. 1990;264:2093-2096. Abstract

7. Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003;327:1271-1275.Full text  Abstract

8. Public Health England. Lassa fever: origins, reservoirs, transmission and guidelines. December 2019 [internet publication].Full text

9. Centers for Disease Control and Prevention. Fact sheet: Lassa fever. June 2015 [internet publication].Full text

10. Nigeria Centre For Disease Control. An update of Lassa fever outbreak in Nigeria. November 2019 [internet publicaton].Full text

11. Shaffer JG, Grant DS, Schieffelin JS, et al. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis. 2014;8:e2748.Full text  Abstract

12. Ehlkes L, George M, Samosny G, et al. Management of a Lassa fever outbreak, Rhineland-Palatinate, Germany, 2016. Euro Surveill. 2017 Sep;22(39).Full text  Abstract

13. World Health Organization. Disease outbreak news. Lassa Fever – The Netherlands (ex –Sierra Leone). November 2019 [internet publication].Full text

14. Centers for Disease Control and Prevention. Viral hemorrhagic fevers: arenaviridae. June 2013 [internet publication].Full text

15. Yun NE, Walker DH. Pathogenesis of Lassa fever. Viruses. 2012;4:2031-2048.Full text  Abstract

16. Eze KC, Salami TA, Kpolugbo JU. Acute abdominal pain in patients with Lassa fever: radiological assessment and diagnostic challenges. Niger Med J. 2014;55:195-200.Full text  Abstract

17. Mahanty S, Bausch DG, Thomas RL, et al. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis. 2001;183:1713-1721.Full text  Abstract

18. Johnson KM, McCormick JB, Webb PA, et al. Clinical virology of Lassa fever in hospitalized patients. J Infect Dis. 1987;155:456-464. Abstract

19. Monath TP, Newhouse VF, Kemp GE, et al. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science. 1974;185:263-265. Abstract

20. Ter Meulen J, Lukashevich I, Sidibe K, et al. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg. 1996;55:661-666. Abstract

21. Lunkenheimer K, Hufert FT, Schmitz H. Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol. 1990;28:2689-2692.Full text  Abstract

22. Fisher-Hoch SP, Tomori O, Nasidi A, et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ. 1995;311:857-859.Full text  Abstract

23. Monath TP, Mertens PE, Patton R, et al. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg. 1973;22:773-779. Abstract

24. Haas WH, Breuer T, Pfaff G, et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis. 2003;36:1254-1258.Full text  Abstract

25. Fisher-Hoch SP, Price ME, Craven RB, et al. Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet. 1985;2:1227-1229. Abstract

26. Günther S, Weisner B, Roth A, et al. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis. 2001;184:345-349.Full text  Abstract

27. Dongo AE, Kesieme EB, Iyamu CE, et al. Lassa fever presenting as acute abdomen: a case series. Virol J. 2013;10:123.Full text  Abstract

28. Bausch DG, Rollin PE, Demby AH, et al. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol. 2000;38:2670-2677.Full text  Abstract

29. Fisher-Hoch S, McCormick JB, Sasso D, et al. Hematologic dysfunction in Lassa fever. J Med Virol. 1988;26:127-135. Abstract

30. McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314:20-26. Abstract

31. Schmitz H, Köhler B, Laue T, et al. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect. 2002;4:43-50. Abstract

32. Boggild AK, Esposito DH, Kozarsky PE, et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med. 2015;162:757-764.Full text  Abstract

33. World Health Organization. WHO recommended surveillance standards - second edition [internet publication]Full text

34. Bausch DG, Hadi CM, Khan SH, et al. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis. 2010;51:1435-1441.Full text  Abstract

35. Department of Health. Management of hazard group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence. November 2015 [internet publication].Full text

36. World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for front-line health workers. February 2016 [internet publication].Full text

37. Cross RW, Mire CE, Branco LM, et al. Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. Antiviral Res. 2016;133:218-222.Full text  Abstract

38. Oestereich L, Rieger T, Lüdtke A, et al. Efficacy of favipiravir alone and in combination with ribavirin in a lethal, immunocompetent mouse model of Lassa fever. J Infect Dis. 2016;213:934-938.Full text  Abstract

39. Buba MI, Dalhat MM, Nguku PM, et al. Mortality among confirmed Lassa fever cases during the 2015-2016 outbreak in Nigeria. Am J Public Health. 2017 Dec 21:e1-e3.Full text  Abstract

40. Liao BS, Byl FM, Adour KK. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause. Otolaryngol Head Neck Surg. 1992;106:226-229. Abstract

41. Solbrig MV, McCormick JB. Lassa fever: central nervous system manifestations. J Trop Geogr Neurol. 1991;1:23-30.

42. Hirabayashi Y, Oka S, Goto H, et al. An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis. 1988;158:872-875. Abstract

Use of this content is subject to our disclaimer